Chronic obstructive pulmonary disease (COPD)
Chronic obstructive pulmonary disease (COPD)
Around one in every 20 Australians aged 45 years and over suffers from chronic obstructive pulmonary disease.
What is COPD?
What causes COPD?
Our COPD research
Hudson Institute scientists have discovered that COPD could be diagnosed and treated earlier, preventing the progression of the disease in thousands of patients. They are working on a blood test to bring the discovery to patients.
Drug halts progression of emphysema and lung cancer
The team found that a drug called sgp130Fc could halt the progression of lung cancer and emphysema. In addition, they have identified a unique signature that could be used to detect both diseases much earlier through a simple blood test. Earlier diagnosis of emphysema will provide patients more treatment options and better quality of life.
Preventing debilitating respiratory infections
This project is investigating whether blocking a protein called Transforming growth factor-β (TGFB), which drives scarring in the lungs of asthma and COPD patients, may also help to prevent bacterial and viral infections in the lungs.Finding new treatment strategies that limit the severity of viral exacerbations of COPD
COPD news
COPD collaborators
- Professor Stefan Rose-John from the University of Kiel
- Monash Health
- Industry Partners Australia
- Commercial partners in Australia and the USA
Support for people with COPD
Hudson Institute scientists cannot provide medical advice.
If you would like to find out more information about COPD, please visit
Keep up-to-date with our latest discoveries
